Shaily Engineering Promoters Hold Nil Encumbrance on Shares

1 min read     Updated on 21 May 2026, 07:25 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Shaily Engineering Plastics Limited disclosed that its promoters hold 1,99,42,600 shares, or 43.40% of the total, with nil encumbrance as of March 31, 2026. The filing, compliant with SEBI regulations, lists 14 individuals in the promoter and promoter group categories.

powered bylight_fuzz_icon
40874141

*this image is generated using AI for illustrative purposes only.

Shaily Engineering Plastics Limited has informed the stock exchanges that its promoters and promoter group hold a significant portion of its equity shares without any encumbrance. The disclosure, dated April 3, 2026, was submitted to BSE Limited and the National Stock Exchange of India Limited in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Details

The promoters and persons acting in concert (PAC) declared that they hold 1,99,42,600 equity shares in Shaily Engineering Plastics Limited . This stake constitutes 43.40% of the company's total shareholding as on March 31, 2026. The company confirmed that no shares were encumbered or pledged by the promoters during the financial year ended on the same date.

Promoter and Promoter Group List

The disclosure included a detailed list of individuals classified as promoters or members of the promoter group. The list comprises 14 names, including Mahendra Bhogilal Sanghvi, Laxman Sanghvi, and Tilottama Sanghvi, who are identified as promoters. The remaining individuals, such as Sanghvi Amit Mahendra and Jayessh Mohanlal Shah, are classified as part of the promoter group.

Sr. # Name of Promoter & Promoter Group Status
1 Mahendra Bhogilal Sanghvi Promoter
2 Laxman Sanghvi Promoter
3 Tilottama Sanghvi Promoter
4 Sanghvi Amit Mahendra Promoter Group
5 Jayessh Mohanlal Shah Promoter Group
6 Kalpana Sanghvi Promoter Group
7 Purnima Mohanlal Shah Promoter Group
8 Ramesh H Shah Promoter Group
9 Lax Nagda Promoter Group
10 Lt. Bharat Bhogilal Sanghvi Promoter Group
11 Vanita L Nagda Promoter Group
12 Shaily Mahendra Sanghvi Promoter Group
13 Rajen Bharat Sanghvi Promoter Group
14 Rashmi Sanghvi Promoter Group

Regulatory Compliance

The filing was signed by Mahendra Bhogilal Sanghvi, an authorised signatory, on behalf of the promoters and promoter group. The confirmation of nil encumbrance provides transparency regarding the financial standing of the company's key stakeholders as of the end of the fiscal year 2026.

Historical Stock Returns for Shaily Engineering Plastics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.08%-3.52%+46.43%+8.79%+50.75%+567.62%

Could the promoters' decision to maintain a 43.40% stake without any pledging signal potential plans for increasing their shareholding through open market purchases or a creeping acquisition in FY2027?

How might the nil encumbrance status influence institutional investor confidence and potentially impact Shaily Engineering Plastics' stock liquidity and valuation multiples going forward?

Given the relatively concentrated promoter holding at 43.40%, are there any regulatory or strategic pressures that could push the company toward increasing its public float in the near future?

Shaily Engineering Plastics
View Company Insights
View All News
like18
dislike

Shaily Engineering Plastics secures USFDA, Canada nod for ShailyPen Neo

1 min read     Updated on 21 May 2026, 05:56 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Shaily Engineering Plastics announced that its strategic partner Orbicular Pharmaceutical Technologies launched a generic Semaglutide injection in Canada using the ShailyPen Neo platform. The product secured USFDA Tentative Approval, Health Canada Notice of Compliance, and Indian CDSCO approval. The ShailyPen Neo is a spring-driven, variable and fixed dose pen injector compatible with ISO-standard 3 mL cartridges.

powered bylight_fuzz_icon
40817581

*this image is generated using AI for illustrative purposes only.

Shaily Engineering Plastics has announced that its strategic partner, Orbicular Pharmaceutical Technologies, has launched a generic version of Semaglutide injection in Canada. This launch incorporates Shaily’s proprietary spring-driven ShailyPen Neo™ pen platform. The combination product has been commercially available in India since March 2026 and has secured USFDA Tentative Approval, along with a Notice of Compliance from Health Canada and approval from the Indian CDSCO.

Regulatory Approvals and Platform Details

The ShailyPen Neoâ„¢ platform is a high-performance, variable and fixed dose pen injector. It offers full compatibility with ISO-standard 3 mL cartridges, supporting both 3 mL and 1.5 mL fill volumes. Shaily Engineering Plastics was responsible for the full design, development, manufacturing, and supply of the device components used in the approved combination product.

Regulatory Approvals Device Platform Cartridge Format
USFDA TA • Health Canada • India CDSCO ShailyPen Neo™ • Variable & Fixed Dose ISO 3 mL • 1.5 mL fill

Strategic Significance

Amit Sanghvi, Managing Director of Shaily Engineering Plastics, highlighted that spring-driven pen injector technology operates within a highly restricted IP environment. He noted that bringing this platform to regulatory approval required significant investment in design and industrial manufacturing. The company focuses on developing complex drug delivery systems, including pen injectors and autoinjectors, for global pharmaceutical markets.

Historical Stock Returns for Shaily Engineering Plastics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.08%-3.52%+46.43%+8.79%+50.75%+567.62%

When does Shaily Engineering Plastics expect to convert its USFDA Tentative Approval into a full approval, and what milestones or patent expirations are required to trigger a US market launch?

How might Shaily's ShailyPen Neoâ„¢ platform be positioned to capture additional GLP-1 drug partnerships beyond Semaglutide, given the growing pipeline of obesity and diabetes injectables?

What is the estimated market size opportunity for Shaily in Canada and the US combined, and how significantly could this impact the company's revenue mix over the next 2-3 years?

Shaily Engineering Plastics
View Company Insights
View All News
like16
dislike

More News on Shaily Engineering Plastics

1 Year Returns:+50.75%